Laboratory Smallpox Stocks: Biosecurity Risks and Debate
Primary Risks
- Bioterrorism: Potential theft or misuse to create a weapon.
- Accidental Release: Lab escape could spark a pandemic (smallpox is highly contagious, ~30% fatality, no cure).
- Worker Exposure: Even minimal exposure can be fatal; requires maximum containment (BSL‑4).
Current Status
Smallpox eradicated in 1980. Two WHO‑authorized repositories remain (CDC Atlanta, VECTOR Russia) for research on vaccines, antivirals, diagnostics.
Risk‑Benefit Consideration
Research benefits (improved countermeasures) must be weighed against catastrophic risks. Ongoing debate about destroying remaining stocks versus retaining for preparedness.
Viral Infections - Related Articles
- Understanding Shingles: Symptoms, Causes & Diagnosis
- Antiviral Drugs: Understanding Treatment and Applications
- West Nile Virus: Symptoms, Transmission & Prevention
- Serious Skin Problems: Skin Cancer Types and Burns
- Flu Shots for Babies: Live vs. Inactivated Vaccines - What You Need to Know
- Swine Flu (H1N1) Virus Survival: Duration on Surfaces & In Hosts
- Understanding Plague: Stages, Symptoms & Causes
